About
This program of work explores the capacity of institutions with formal or effective regulatory authority to influence the quality and availability of environmental data and/or the environmental performance of pharmaceuticals and other health technologies.
Key activities:
- A CIHR-funded policy study that explores how market access regulators (e.g. Health Canada, US FDA), and coverage and reimbursement advisors such as Health Technology Assessment agencies (e.g., Canadian Drug Agency, UK NICE) are addressing the environmental harms of pharmaceuticals and other health technologies
- In partnership with the WHO Collaborating Centre, the Collaborative Centre hosted a Research Roundtable on Pharmaceuticals & The Environment featuring visiting expert Stefan Berggren from Swedish Medical Products Agency
- We also hosted meetings with Health Canada, Environment & Climate Change Canada and the Canadian Drug Agency
Lead(s)
Fiona A. Miller
Director, Collaborative Centre for Climate, Health & Sustainable Care, Director, CASCADES University of Toronto
Gillian Parker
Program Coordinator, Climate, Health & Sustainable Care Student Training Program